2001
DOI: 10.1002/1097-0142(20010715)92:2<225::aid-cncr1313>3.0.co;2-b
|View full text |Cite
|
Sign up to set email alerts
|

The development of breast carcinoma in women with thyroid carcinoma

Abstract: BACKGROUND Breast carcinoma and thyroid carcinoma are two malignancies that occur most commonly in women. An association between the incidence rates of thyroid and breast carcinoma in women after a diagnosis of the other malignancy has been suggested in a retrospective analysis of a single institution's tumor registry. In that study, an increased incidence of breast carcinoma in premenopausal women previously treated for thyroid carcinoma was observed. METHODS The purpose of this study was to investigate furth… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
56
1
4

Year Published

2003
2003
2016
2016

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 106 publications
(63 citation statements)
references
References 14 publications
2
56
1
4
Order By: Relevance
“…In fact, some population-based cohort studies indicate an increase of thyroid cancer after breast cancer treatment and an increase of breast cancer after thyroid cancer (Ron et al, 1984;Teppo et al, 1985;Li et al, 2000). However, other studies only identified an increased risk of breast cancer after thyroid cancer treatment (Vassilopoulou-Sellin et al, 1999;Chen et al, 2001).…”
Section: Discussionmentioning
confidence: 99%
“…In fact, some population-based cohort studies indicate an increase of thyroid cancer after breast cancer treatment and an increase of breast cancer after thyroid cancer (Ron et al, 1984;Teppo et al, 1985;Li et al, 2000). However, other studies only identified an increased risk of breast cancer after thyroid cancer treatment (Vassilopoulou-Sellin et al, 1999;Chen et al, 2001).…”
Section: Discussionmentioning
confidence: 99%
“…The risk of secondary malignancies is dose-related (267). There appears to be an increased risk of breast cancer in women with thyroid cancer (270). It is unclear whether this is the result of screening bias, radioiodine therapy, or other factors.…”
Section: Differentiated Thyroid Cancer: Management Guidelinesmentioning
confidence: 99%
“…A mellrák tekintetében a gyakoribb előfordu-lást nem a 131 I-expozícióval magyarázták (az emlőmirigy sejtjei ugyan NIS-t expresszálnak, de radiojódkezelés után a mell nem vizualizálható), ennek ellenére a fokozott rizikó kimutatható [49]. Mivel a gyomor, a nyálmi-rigyek és a hólyag kapja a legnagyobb besugárzási dózist, igen fontos a kezelés utáni ápolási protokoll (bő folyadék, szekretagógok alkalmazása, hashajtás stb.).…”
Section: A Radiojódterápia Késői Mellékhatásaiunclassified